The major questions in protein targeting can be phrased relatively simply: what are the signals that direct a protein to a particular location in a cell? what are the cellular components that recognize the targeting signals? and how is the targeting event achieved? In the case of targeting to and translocation across the membrane of the endoplasmic reticulum (ER), these questions have been answered to a great degree of satisfaction (reviewed by Walter and Johnson, 1994) . Signal sequences have been defined that can both direct reporter proteins to the ER membrane and initiate the process of translocation (a large number of sequences work in this capacity, and the main determining feature seems to be hydrophobicity). Two components have been shown to be required in mammalian cells for the targeting event per se: a cytoplasmic ribonucleoprotein called the signal recognition particle (SRP) binds with high affinity to ribosomes synthesizing proteins destined for the ER and also has affinity for a resident ER membrane protein (SRP receptor), thereby achieving the targeting event.
For transiocation across the ER, a second component in the membrane, a heterotrimeric complex known as the Sec61p complex is required. The complex is thought to be the main constituent of a protein-conducting channel. Using in vitro reconstituted proteoliposomes to create a target membrane consisting of defined components, it has been possible to determine exactly which components are sufficient for translocation. It was found that SRP, SRP receptor, and the Sec61p complex were sufficient for the targeting and translocation of some polypeptides. For other polypeptides, translocation was stimulated in the presence of an additional ER membrane protein known as the TRAM (for translocating chain-associating membrane) protein. During translocation itself, neither SRP nor its receptor is thought to be required.
Upon reflection, this model is somewhat puzzling. One might have predicted something much simpler: an ER membrane component that recognizes signal sequences directly. In fact, in bacteria, there is evidence that PrlA/ SecY, the bacterial homolog of the a subunit of the Sec61 p complex (GSrlich et al., 1992) , discriminates between secretory and nonsecretory proteins, as mutations in prlA/ secY suppress signal sequence mutations (Emr et al., 1981; Derman et al., 1993) . In this issue of Cell, Jungnickel an d Rapoport demonstrate that a second signal recognition event occurs within the ER membrane and that this recognition event, as in bacteria, involves the Sec61p complex° Furthermore, by creating an assay system in which the nascent chain-ribosome precursor is purified away from the cytoplasmic extract used to synthesize it, these authors bypass the requirement for SRP and SRP receptor in protein targeting and show that the Sec61p complex in proteoliposomes is sufficient to direct translocation into the ER.
A Second Signal Recognition Event in the ER Membrane
The identification of components that recognize signal sequences was made feasible by two advances: the ability to generate a stable functional intermediate of the process and the ability to insert protein cross-linkers into the signal sequence and thereby identify proteins close to it at various stages of the translocation process. One intermediate can be generated using SRP itself, which under certain circumstances stably arrests the elongation of the secretory protein preprolactin in the absence of ER membranes. Additional intermediates could be generated using as the template for protein synthesis mRNAs lacking termination signals (usually truncated mRNAs), thus leading to the synthesis of nascent proteins that could not be released from the ribosome.
It was found that the preprolactin nascent chain arrested by SRP itself could be cross-linked to the 54 kDa subunit of SRP (SRP54) (reviewed by Walter and Johnson, 1994) , leading to the idea that this subunit contains the signal recognition activity of SRP. Other components in proximity to the signal sequence have been identified using truncated mRNAs to generate nascent chains of various lengths (see Walter and Johnson, 1994 , and references therein). Jungnickel and Rapoport (1995) used this approach and generated preprolactin nascent chains ranging from 43 to 86 amino acids in length. They found that chains 51 amino acids in length or longer could be crosslinked to SRP54 (maximum cross-linking efficiency was reached at 59 amino acids in length and remained constant with longer chains). Upon addition of ER vesicles, two new cross-links appeared: one to the a subunit of Sec61 p (which also appeared at a chain length of 51 amino acids and reached a maximum at 59 amino acids in length) and a second to the TRAM protein (beginning at 64 amino acids in length).
Does cross-linking of the nascent chain to Sec61(~ imply that a recognition event has taken place, or does it merely reflect a proximity of the nascent chain to this membrane protein (which, after all, is thought to comprise the major transmembrane constituent of the translocation channel)? In other words, can Sec61(~, TRAM protein, or both discriminate among different signal sequences? To address this question, Jungnickel and Rapoport (1995) first looked at the effect of a mutant signal sequence on translocation and cross-linking efficiency. They found that deleting three hydrophobic leucine residues from the preprolactin signal sequence did not greatly affect cross-linking efficiency to SRP54 or to Sec61(~, nor did it eliminate cross-linking to TRAM protein; in contrast, this deletion led to dramatic decreases in translocation efficiency. This result shows that some event in translocation can discriminate between wild type and this particular mutant signal sequence, but does not define the step in which the discrimination occurs.
To address directly whether a signal sequence discrimi-natory event exists in the ER membrane, Jungnickel and Rapoport (1995) generated an assay system in which the influence of SRP in targeting could be excluded. Previous studies from the Rapoport lab showed that purified saltwashed ribosomes could be bound to the Sec61 p complex under physiological salt concentrations (Kalies et al., 1994) . Jungnickel and Rapoport (1995) as well as Lauring et al. (1995a) made nascent chain-ribosome complexes containing the 86 amino acid long preprolactin nascent chain and then purified the complexes by sedimentation though a sucrose cushion in high salt. They found that nascent chains from these complexes could be translocated across ER vesicles in the complete absence of SRP. This result is interesting in itself, but for the moment, let us consider it simply in light of the fact that we now have an assay for a signal sequence discriminatory event in the ER membrane. Jungnickel and Rapoport (1995) found that preprolactin nascent chains containing the signal sequence mutation, in contrast with wild-type nascent chains, were not efficiently translocated, even though they did initially bind to the ER membrane. Furthermore, in a highly purified system using purified nascent chain-ribosome complexes and in vitro reconstituted proteoliposomes, they were able to show that translocation required only the Sec61 p complex in proteoliposomes and was still signal sequence discriminatory. In neither case did the addition of SRP and SRP receptor increase the percentage of chains translocated. Nascent Chain-Ribosome Complexes Contain an Inhibitor of Targeting Thus, under certain experimental conditions, protein targeting to the ER membrane can occur without SRP or SRP receptor and yet by a mechanism that is still signal sequence discriminatory. This finding is quite satisfying. It says that at the heart of ER targeting, the simple situation really does hold: there is a component in the ER membrane that seems to recognize the signal sequence directly. As in bacteria, this component seems to be the Sec61p complex. It also tells us that the process becomes dependent on SRP at least in part because of the presence of some inhibitor that can be removed by salt extraction of the nascent chain-ribosome complex. What does this inhibitor do, and what is it?
A clue comes from comparing the association of wildtype and mutant preprolactin chains in the crude (inhibitorcontaining) and purified (inhibitor-depleted) systems. In the presence of inhibitor, mutant nascent chains were found to bind to ER vesicles, but many of the chains were removed from the vesicles by subsequent salt extraction. In contrast, in the absence of inhibitor, neither the mutant nor the wild-type preprolactin chains could be removed from the ER vesicles by subsequent salt extraction. This suggests that the inhibitor blocks the salt-resistant binding of the nascent chain-ribosome complex to the Sec61p complex.
Recently, a heterodimeric protein complex called nascent polypeptide-associated complex (NAC) was identified (Wiedmann et al., 1994) . This complex can be crosslinked to all nascent chains (i.e., polypeptides still associated with the ribosome) and can be removed from ribosomes with salt extraction. Lauring et al. (1995a) found that purified NAC blocks the salt-resistant binding of purified nascent chain-ribosome complexes to the ER membrane. This result strongly suggests that the inhibitor defined in the Jungnickel and Rapoport (1995) study is NAC.
The effect of NAC on salt-resistant binding of nascent chain-ribosome complexes to the ER membrane does not seem to depend on the sequence of the nascent chain. Lauring et al. (1995a) showed that, in the absence of NAC, even nascent chains lacking signal sequences were targeted and even translocated, albeit less efficiently than signal-containing nascent chains. Conversely, the addition of NAC in the absence of SRP blocked the association of even signal sequence-containing nascent chain-ribosome complexes to the membrane (Lauring et al., 1995b) .
The finding that SRP counteracts the negative effect on targeting of NAC, a protein that cross-links to polypeptide chains only in the context of the ribosome, lends support to the idea that the interaction of SRP with the ribosome is critical for its function. A recent study by Ogg and Walter (1995) offers a striking demonstration of this. A temperature-sensitive mutation in the SEC65 gene (which encodes an SRP subunit) causes growth and protein translocation defects. These defects can be suppressed by sublethal doses of the protein elongation inhibitor cycloheximide. Another elongation inhibitor, anisomycin, which blocks at a different stage in the elongation cycle, has no effect. To interpret these results, we must realize that elongation inhibitors slow elongation only at the step at which they act; the rest of the elongation cycle progresses at the normal rate. Because one elongation inhibitor works to suppress the phenotype caused by decreasing the amount of SRP and another inhibitor does not work, we can conclude that SRP interacts with the ribosome at the particular phase in the elongation cycle at which the effective inhibitor acts. The ribosome thus plays an active role in SRPmediated targeting and does not simply hold the nascent chain in a conformation to which SRP can bind.
The finding that protein translocation can occur at all in the absence of SRP leads to the question of whether the involvement of SRP in the targeting of secretory nascent chains has evolved relatively recently. However, the isolation of SRP54 homologs in bacteria (reviewed by Wolin, 1994) and in chloroplasts (Li et al., 1995) and the demonstration that these homologs are used in targeting suggest that the involvement of SRP in this process is quite old. The chloroplast case is particularly interesting because it seems that this is the only case in which an SRP-mediated signal recognition event seems not to require association with ribosomes. However, since the signal that is recognized by chloroplast SRP54 is distinct from an ER signal sequence and because chloroplast SRP54 seems to be part of an as-yet-uncharacterized multisubunit complex, further work is necessary before we will fully understand this finding.
Additional Membrane Components May Increase the Efficiency of Translocation
Although the salt-extracted nascent chain-ribosome complexes are substrates for translocation across proteolipo-somes containing only the Sec61p complex, certain aspects of targeting differ between translocation across proteoliposomes and translocation across ER-derived vesicles (Jung nickel and Rapoport, 1995) , which suggests that in the intact membranes, additional factors are involved. For example, less wild-type preprolactin was found bound in a salt-resistant state to reconstituted proteoliposomes than to ER membranes. In addition, a significant fraction of mutant signal sequence-containing nascent chains were completely protected from proteolysis by ER membranes but not by proteoliposomes. Perhaps this is not so surprising given the fact that a rather large complex (the nascent chain-ribosome) needs to interact with the membrane; one might imagine that additional factors could increase the efficiency or the stability (or both) of the interaction.
Posttranslational Protein Transport Requires Additional Components
In the cotranslational mode of protein transport, the ribosome plays a central role not only in initiating translocation, as has been described here, but also in conferring directionality to the process. Johnson and coworkers (Crowley et al., 1994) have shown that the ribosome plays an instrumental role in generating a tight seal on the cytoplasmic side of the ER membrane. Because of this seal, there is no option but for the secretory protein to be transferred into the lumen of the ER. Given this, it is extremely interesting that a second mode of protein transport exists that is not in any way dependent on ribosomes. One would like to know whether, in this case, the same components are sufficient to direct translocation into the ER.
ER membranes from Saccharomyces cerevisiae have been shown to support posttranslationai protein transport. To determine the nature of the factors involved in posttranslational protein transport, Panzer et al. (1995) purified Sec61 p-containing complexes from yeast. They found that the Sec61p complex existed in two forms, a heterotrimeric form (Sec61p, Ssslp, and Sbhlp) that was associated with ribosomes and a larger form containing four additional membrane proteins (Sec62p, Sec63p, Sec71p, and Sec72p) that had been implicated in protein translocation on genetic grounds. It is assumed that the heterotrimeric complex, as in the mammalian system, could mediate cotranslational protein transport; this is not yet known, however, as an in vitro assay for cotranslational transport in yeast has not yet been defined. The complex containing the seven polypeptides and not the heterotrimeric complex could, when reconstituted into proteoliposomes, support posttranslational translocation. It seems as if this larger complex is used only for posttranslational protein transport since it is never seen associated with ribosomes. The efficiency of translocation was increased in the presence of Kar2p (BiP), a lumenal protein that has been shown to bind incoming polypeptide chains (Sanders et al., 1992) , and ATP. The addition of these components may provide a directionality to the process, which in the cotranslational case is most likely conferred by the ribosome.
The presence of two different complexes that support different modes of translocation provide the cell with an ability to regulate the system. It will be interesting to determine whether the relative abundance of the two complexes is altered depending on the growth requirements of the cell or in response to specific mutations that affect different modes of transport. Furthermore, reduction in the level of yeast NAC may allow continued cotranslational protein transport even in cases in which yeast SRP is limiting.
Summary
As summarized in this minireview, two different signal recognition events, one involving SRP and the other involving proteoliposomes containing the Sec61p complex, have been identified. In cotranslational protein transport, it seems that both recognition events are required for efficient translocation of the protein into the lumen of the ER. The requirement for SRP can, under certain experimental conditions, be circumvented by depletion of NAC, a heterodimeric complex that can block the tight association of nascent chain-ribosome complexes to the Sec61p complex in the ER membrane. In posttranslational protein transport, the Sec61p complex contains additional protein subunits that are required for function.
It should be noted that, in all the experiments performed in which the role of SRP in cotranslational protein translocation is circumvented (Jungnickel and Rapoport, 1995; Lauring et al., 1995a Lauring et al., , 1995b , stable translocation intermediates are allowed many minutes to establish productive interactions with the membrane. In contrast, during conditions in which the nascent chain can elongate (e.g., in vivo), the nascent chain-ribosome complex only has a brief time window during which it can initiate translocation (reviewed by Walter and Johnson, 1994) . It is possible that, under these conditions, productive translocation even in the absence of NAC would require SRP. The isolation of NAC-deficient extracts that support protein synthesis will allow a test of this possibility.
Finally, the role that lipids themselves may play in protein transport should not be ignored. Gierasch and coworkers (Hoyt and Gierasch, 1991, and references therein) have shown that bacterial signal peptides have an intrinsic ability to interact with lipid and that the relative ability of a mutant signal sequence to interact with lipid correlates with its function as a signal sequence in vivo. Thus, the signal sequence-discriminatory role defined by Jungnickel and Rapoport (1995) may in fact be played by lipid, with the Sec61p complex playing a necessary but nondiscriminatory role in the process. In this light, it is interesting that Martoglio et al. (1995) recently demonstrated that the signal sequence of preprolactin could be cross-linked to phospholipid. Analysis of the cross-linking efficiency of the signal sequence to phospholipid at different nascent chain lengths and with mutant signal sequences will help define the role that phospholipid plays in the process.
